During a hearing before Congress over the EpiPen price hike scandal, Mylan CEO Heather Bresch called the outraged reactions to the price hike “overblown.” (AP photo)

Big Pharma Accused Of Illegal Price-Fixing, What You’re Not Being Told

The suit is part of an ongoing, two-year long antitrust investigation conducted by the U.S. Department of Justice.

Regístrate para lo mejor de MintPress, entregado a tu bandeja de entrada diaria.

Regístrese para nuestro Resumen diario.